Conference abstract · 17 Oct 2016
EditorialPublished 2013
ACE-Inhibitors in High Vascular Risk: From Experimental Medicine to Clinical Trials
Similar by topic
Research article · 25 Apr 2022
Risk of Developing Alzheimer’s Disease and Related Dementias in ALLHAT Trial Participants Receiving Diuretic, Ace-Inhibitor, or Calcium-Channel Blocker with 18 Years of Follow-Up
Case report · 2021
Risk factors for ACE-inhibitors use in Individuals Affected by COVID-19
Article · 1 Jul 2016
A clinical trial investigating the effect of trimetazidine combined with oxiracetam in patients with vascular dementia.
Article · 26 Jun 2024
Pharmacology of Angiotensin Receptor Blockers (ARBs) and ACE Inhibitors in Cardiovascular Disease
More from this journal
The newest in Cardiovascular Pharmacology: Open Access.
Article · 28 Jun 2025
Advances in Antiplatelet Therapy for Secondary Prevention of Myocardial Infarction
Article · 28 Jun 2025
Beta Blockers and Their Expanding Role in Cardiovascular Disease
Article · 28 Jun 2025
Emerging Role of PCSK9 Inhibitors in Lipid Management
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCardiovascular Pharmacology: Open Access
- SubjectPharmaceutical Sciences
- SubjectCardiology
- BylineArticles whose byline prints “Fabio Angeli”
- BylineArticles whose byline prints “Gianpaolo Reboldi”
- BylineArticles whose byline prints “Cristina Poltronieri”
- BylineArticles whose byline prints “Paolo Verdecchia”

